Erratum (DOI:10.1016/j.juro.2009.02.130);Effect of Body Mass Index and Waist Circumference on Prostate Specific Antigen and Prostate Volume in a Generally Healthy Korean Population

Journal of Urology

Volumn 182, Issue 1, 2009, Pages 106-111

  Park, Jin Ho ^a   Cho, Be Long ^b   Kwon, Hyuk Tae ^a   Lee, Cheol Min ^a   Han, Hyun Jin ^c  

^a Seoul National University Hospital Healthcare System Gangnam Center   (South Korea)

^b Seoul National University Hospital   (South Korea)

^c Seoul National University   (South Korea)

Author keywords

body mass index; mass screening; organ size; prostate specific antigen; waist circumference

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BODY MASS; CONTROLLED STUDY; HUMAN; KOREA; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; OBESITY; ORGAN SIZE; PRIORITY JOURNAL; ULTRASOUND; WAIST CIRCUMFERENCE;

EID: 67349178444     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2009.07.006     Document Type: Erratum

References (20)

1. Sarma A.V., and Schottenfeld D. Prostate cancer incidence, mortality, and survival trends in the United States: 1981-2001. Semin Urol Oncol 20 (2002) 3
2. Potosky A.L., Feuer E.J., and Levin D.L. Impact of screening on incidence and mortality of prostate cancer in the United States. Epidemiol Rev 23 (2001) 181
3. Oberaigner W., Horninger W., Klocker H., Schonitzer D., Stuhlinger W., and Bartsch G. Reduction of prostate cancer mortality in Tyrol, Austria after introduction of prostate-specific antigen testing. Am J Epidemiol 164 (2006) 376
4. Oesterling J.E., Jacobsen S.J., Chute C.G., Guess H.A., Girman C.J., Panser L.A., et al. Serum prostate specific antigen in a community-based population of healthy men: establishment of age-specific reference ranges. JAMA 270 (1993) 860
5. Ando R., Nagaya T., Hashimoto Y., Suzuki S., Itoh Y., Umemoto Y., et al. Inverse relationship between obesity and serum prostate-specific antigen level in healthy Japanese men: a hospital-based cross-sectional survey, 2004-2006. Urology 72 (2008) 561
6. Banez L.L., Hamilton R.J., Partin A.W., Vollmer R.T., Sun L., Rodriguez C., et al. Obesity-related plasma hemodilution and PSA concentration among men with prostate cancer. JAMA 298 (2007) 2275
7. Kristal A.R., Chi C., Tangen C.M., Goodman P.J., Etzioni R., and Thompson I.M. Associations of demographic and lifestyle characteristics with prostate-specific antigen (PSA) concentration and rate of PSA increase. Cancer 106 (2006) 320
8. Werny D.M., Thompson T., Saraiya M., Freedman D., Kottiri B.J., German R.R., et al. Obesity is negatively associated with prostate-specific antigen in U.S. men, 2001-2004. Cancer Epidemiol Biomarkers Prev 16 (2007) 70
9. Fowke J.H., Signorello L.B., Chang S.S., Matthews C.E., Buchowski M.S., Cookson M.S., et al. Effects of obesity and height on prostate-specific antigen (PSA) and percentage of free PSA levels among African-American and Caucasian men. Cancer 107 (2006) 2361
10. Barqawi A.B., Golden B.K., O'Donnell C., Brawer M.K., and Crawford E.D. Observed effect of age and body mass index on total and complexed PSA: analysis from a national screening program. Urology 65 (2005) 708
11. Baillargeon J., Pollock B.H., Kristal A.R., Bradshaw P., Hernandez J., Basler J., et al. The association of body mass index and prostate-specific antigen in a population-based study. Cancer 103 (2005) 1092
12. Freedland S.J., Platz E.A., Presti Jr. J.C., Aronson W.J., Amling C.L., Kane C.J., et al. Obesity, serum prostate specific antigen and prostate size: implications for prostate cancer detection. J Urol 175 (2006) 500
13. Capitanio U., Perrotte P., Hutterer G.C., Suardi N., Jeldres C., Shariat S.F., et al. Effect of body mass index on prostate-specific antigen and percentage free prostate-specific antigen: results from a prostate cancer screening cohort of 1490 men. Int J Urol 16 (2009) 91
14. Ochiai A., Fritsche H.A., and Babaian R.J. Influence of anthropometric measurements, age, and prostate volume on prostate-specific antigen levels in men with a low risk of prostate cancer. Urology 66 (2005) 819
15. Ku J.H., Kim M.E., Lee N.K., Park Y.H., and Ahn J.O. Influence of age, anthropometry, and hepatic and renal function on serum prostate-specific antigen levels in healthy middle-age men. Urology 61 (2003) 132
16. World Health Organization, Western Pacific Region, International Association for the Study of Obesity. The Asia-Pacific Perspective: Redefining Obesity and its Treatment (2000), Health Communications Australia Pty Limited, Sydney, Australia
17. Rodriguez C., Freedland S.J., Deka A., Jacobs E.J., McCullough M.L., Patel A.V., et al. Body mass index, weight change, and risk of prostate cancer in the Cancer Prevention Study II Nutrition Cohort. Cancer Epidemiol Biomarkers Prev 16 (2007) 63
18. Wright M.E., Chang S.C., Schatzkin A., Albanes D., Kipnis V., Mouw T., et al. Prospective study of adiposity and weight change in relation to prostate cancer incidence and mortality. Cancer 109 (2007) 675
19. Lee S., Min H.G., Choi S.H., Kim Y.J., Oh S.W., Kim Y.J., et al. Central obesity as a risk factor for prostatic hyperplasia. Obesity 14 (2006) 172
20. Kim M.R., Gupta M.K., Travers S.H., Rogers D.G., Van Lente F., and Faiman C. Serum prostate specific antigen, sex hormone binding globulin and free androgen index as markers of pubertal development in boys. Clin Endocrinol (Oxf) 50 (1999) 203